The protective effects of rapamycin on cell autophagy in the renal tissues of rats with diabetic nephropathy via mTOR-S6K1-LC3II signaling pathway

Abstract Background: Previous studies have shown that podocyte autophagy is an important trigger for proteinuria and glomerulosclerosis. The mammalian rapamycin target protein (mTOR) occupies a pivotal position in the autophagy pathway. In this study, we planned to clarify the mechanism of mTOR regulation of podocyte autophagy and the effect of rapamycin (RAPA). Methods: All rats were randomly divided into normal control group (n = 8), DN group (n = 8), and RAPA group (n = 8). Blood and urine samples were collected at the 4th, 8th, and 12th weeks of the experiment. The serum creatinine (Scr), urine volume levels, and the 24 h urine protein (UP) levels were examined. The nephrin, podocin, mTOR, ribosomal S6 kinase 1 (S6K1), and autophagy marker light chain 3 (LC3II) expression levels were evaluated by immunohistochemistry, quantitative PCR, and immunoblotting. Results: The urine volume, 24 h UP, and Scr of the DN and RAPA groups increased significantly compared with the NC group (p < .05). Nephrin and podocin expression was decreased in the kidney tissues of the DN and RAPA groups compared with the NC group (p < .05). The expression levels of mTOR and S6K1 increased and LC3II expression decreased in the renal tissues of the DN and RAPA groups compared with the NC group (p < .05). After RAPA treatment, all the above indexes were improved compared with the DN group (p < .05), but were significantly abnormal compared with the NC group (p < .05). Conclusion: The proteinuria and kidney function had improved after RAPA treatment. These results confirmed that RAPA specifically binds to mTOR kinase, and inhibits mTOR activity, thereby regulating the pathological autophagic process.

[1]  Li Yu,et al.  Mitochondria: The hub of energy deprivation-induced autophagy , 2017, Autophagy.

[2]  Hong Zhang,et al.  The composition of a protein aggregate modulates the specificity and efficiency of its autophagic degradation , 2017, Autophagy.

[3]  Jianjun Lin,et al.  Catalase ameliorates diabetes‐induced cardiac injury through reduced p65/RelA‐ mediated transcription of BECN1 , 2017, Journal of cellular and molecular medicine.

[4]  Young‐Hee Kang,et al.  Chrysin ameliorates podocyte injury and slit diaphragm protein loss via inhibition of the PERK-eIF2α-ATF-CHOP pathway in diabetic mice , 2017, Acta Pharmacologica Sinica.

[5]  Shiping Ma,et al.  Paeoniflorin ameliorates AGEs-induced mesangial cell injury through inhibiting RAGE/mTOR/autophagy pathway. , 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[6]  Xiang Lu,et al.  Resveratrol protects podocytes against apoptosis via stimulation of autophagy in a mouse model of diabetic nephropathy , 2017, Scientific Reports.

[7]  X. Ruan,et al.  Autophagy Protects against Palmitic Acid-Induced Apoptosis in Podocytes in vitro , 2017, Scientific Reports.

[8]  D. Xiao,et al.  Berberine enhances the AMPK activation and autophagy and mitigates high glucose‐induced apoptosis of mouse podocytes , 2017, European journal of pharmacology.

[9]  Sungha Park,et al.  The Impact of Diabetes Mellitus on Vascular Biomarkers in Patients with End-Stage Renal Disease , 2016, Yonsei medical journal.

[10]  T. Yuan,et al.  Reciprocal regulation of mTOR complexes in pancreatic islets from humans with type 2 diabetes , 2017, Diabetologia.

[11]  Guangjie Wang,et al.  Blocking Mammalian Target of Rapamycin (mTOR) Attenuates HIF-1α Pathways Engaged-Vascular Endothelial Growth Factor (VEGF) in Diabetic Retinopathy , 2016, Cellular Physiology and Biochemistry.

[12]  Zhenfeng Zheng,et al.  Spironolactone promotes autophagy via inhibiting PI3K/AKT/mTOR signalling pathway and reduce adhesive capacity damage in podocytes under mechanical stress , 2016, Bioscience reports.

[13]  J. Zhen,et al.  The renoprotective role of autophagy activation in proximal tubular epithelial cells in diabetic nephropathy. , 2015, Journal of diabetes and its complications.

[14]  Q. Ma,et al.  Effect of simvastatin on the expression of nephrin, podocin, and vascular endothelial growth factor (VEGF) in podocytes of diabetic rat. , 2015, International journal of clinical and experimental medicine.

[15]  M. Cho,et al.  Gemigliptin improves renal function and attenuates podocyte injury in mice with diabetic nephropathy. , 2015, European journal of pharmacology.

[16]  Yang Zhang,et al.  Dysregulation of low-density lipoprotein receptor contributes to podocyte injuries in diabetic nephropathy. , 2015, American journal of physiology. Endocrinology and metabolism.

[17]  T. B. Huber,et al.  Endothelial cell and podocyte autophagy synergistically protect from diabetes-induced glomerulosclerosis , 2015, Autophagy.

[18]  Jinghong Zhao,et al.  Rapamycin promotes podocyte autophagy and ameliorates renal injury in diabetic mice , 2014, Molecular and Cellular Biochemistry.

[19]  M. Haberal,et al.  Rapamycin prevents interstitial fibrosis in renal allografts through decreasing angiogenesis and inflammation. , 2011, Transplantation proceedings.